Table 3.
Demographic and allocation analysis between highest tertile and lower tertiles
| Top 1/3 (n = 33) (Median ± SD) |
Bottom 2/3 (n = 67) (Median ± SD) |
p-value | ||
|---|---|---|---|---|
| Age* | 49.7 ± 8.48 | 50.0 ± 9.29 | 0.995 | |
| Survival time (days) * | 202 ± 264 | 700 ± 702 | <0.0001 | |
| Pre-enrolled time (days) * | 817 ± 820 | 1218 ± 1584 | 0.021 | |
| Baseline TRACP 5b* | 8.006 ± 3.921 | 3.063 ± 1.050 | <0.0001 | |
| CEA* | 5.34 ± 83.02 | 2.50 ± 1102 | 0.577 | |
| CA 15.3* | 196.7 ± 648.06 | 32.59 ± 142.42 | <0.0001 | |
| Visceral metastasis** | Positive | 22 | 35 | 0.248 |
| Negative | 11 | 32 | ||
| ER** | Positive | 16 | 47 | 0.156 |
| Negative | 12 | 16 | ||
| HER** | Positive | 6 | 12 | 1.00 |
| Negative | 19 | 38 | ||
| Prior chemotherapy ** | None | 4 | 14 | 0.619 |
| One line | 16 | 30 | ||
| ≥ 2 lines | 7 | 16 |
*: Student t test (2-tailed)
**: Chi-Square